The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frick, A. G.
Right arrow Articles by Look, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frick, A. G.
Right arrow Articles by Look, D. C.
The Journal of Immunology, 2000, 164: 4185-4196.
Copyright © 2000 by The American Association of Immunologists

Haemophilus influenzae Stimulates ICAM-1 Expression on Respiratory Epithelial Cells1

Annette G. Frick*, Theresa D. Joseph*, Liyi Pang*, Autumn M. Rabe*, Joseph W. St. Geme, III{dagger} and Dwight C. Look2,*

Departments of * Medicine and {dagger} Pediatrics and Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Epithelial cells interact directly with bacteria in the environment and play a critical role in airway defense against microbial pathogens. In this study, we examined the response of respiratory epithelial cells to infection with nontypable Haemophilus influenzae. Using an in vitro cell culture model, we found that epithelial cell monolayers released significant quantities of IL-8 and expressed increased levels of ICAM-1 mRNA and surface protein in response to H. influenzae. In contrast, levels of IL-1ß, TNF-{alpha}, and MHC class I were not significantly affected, suggesting preferential activation of a specific subset of epithelial genes directed toward defense against bacteria. Induction of ICAM-1 required direct bacterial interaction with the epithelial cell surface and was not reproduced by purified H. influenzae lipooligosaccharide. Consistent with a functional role for this response, induction of ICAM-1 by H. influenzae mediated increased neutrophil adherence to the epithelial cell surface. Furthermore, in an in vivo murine model of airway infection with H. influenzae, increased epithelial cell ICAM-1 expression coincided with increased chemokine levels and neutrophil recruitment in the airway. These results indicate that ICAM-1 expression on human respiratory epithelial cells is induced by epithelial cell interaction with H. influenzae and suggest that an ICAM-1-dependent mechanism can mediate neutrophil adherence to these cells independent of inflammatory mediator release by other cell types. Direct induction of specific epithelial cell genes (such as ICAM-1 and IL-8) by bacterial infection may allow for rapid and efficient innate defense in the airway.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Epithelial cells in the respiratory system are not passive bystanders during assault of the epithelial barrier but participate actively in the inflammatory response to defend the airway (1). Because epithelial cells are located at sites of contact with the external environment, they are often the first cells to interact with potential microbial pathogens. Indeed, bacterial adherence to epithelial cells may be a prerequisite for colonization and infection (2, 3), and through this interaction epithelial cells may have the opportunity to detect and respond to pathogens independent of signals from other cell types in the respiratory system. The capacity for epithelial cells to directly detect microbial pathogens and immediately initiate expression of genes directed toward defense may allow for more efficient activation of the inflammatory response. Although several molecules that participate in airway defense have been identified, the activation and coordination of factors that result in a rapid and effective inflammatory response at the epithelial surface are only beginning to be elucidated.

One mechanism for epithelial cells to participate in airway defense is through coordination of leukocyte influx and activation by expression of adhesive surface proteins and secretion of chemotactic molecules. Increased cell-surface expression of the adhesive glycoprotein ICAM-1 in response to inflammatory stimuli is one important example of epithelial cell contribution to leukocyte recruitment (4, 5). The interaction of ICAM-1 with CD18/ß2 integrin-containing counterreceptors on leukocytes is a crucial mechanism for leukocyte adhesion and activation by airway epithelial cells (4, 6, 7). A second example of epithelial cell capacity to coordinate leukocyte influx in the airway is by secretion of the CXC chemokine IL-8, which targets neutrophils to sites of attack through its chemoattractant and activating properties (8). Although pathways for airway epithelial cell expression of cell adhesion molecules and secretion of mediator molecules in response to inflammatory cytokines and viruses have been described (4, 9, 10, 11), the role of epithelial cells in the airway response to bacterial infection is less well developed. However, pilin-mediated adherence of Pseudomonas aeruginosa has been shown to stimulate airway epithelial cell production of IL-8 (12, 13), providing precedent for the possibility that epithelial cells in the respiratory system initiate leukocyte recruitment following direct detection of bacterial stimuli. Based on the fact that the human lung is exposed to many different bacterial species, it seems logical that multiple detection mechanisms may have evolved to allow epithelial cells to respond effectively to a wide variety of potentially pathogenic microbes.

Haemophilus influenzae is a pleomorphic Gram-negative bacillus that frequently colonizes human respiratory mucosa and often produces localized respiratory tract disease (14, 15). Encapsulated isolates of H. influenzae are designated serotypes a–f on the basis of expression of one of six antigenically distinct polysaccharide capsules (3). Isolates of H. influenzae that fail to agglutinate with typing antisera against known capsular structures are designated nontypable. Although serotype b strains account for most cases of bacteremic and systemic illness due to H. influenzae, infection with this serotype is becoming less common due to recent widespread use of vaccines directed against the serotype b capsule (15). We have focused on nontypable strains because these organisms are responsible for the majority of disease caused by H. influenzae that is localized to the respiratory tract, including otitis media, sinusitis, bronchitis, and pneumonia (15, 16). Patients with chronic bronchitis, bronchiectasis, and cystic fibrosis are particularly predisposed to infection with nontypable H. influenzae (14, 17). Direct contact between H. influenzae and airway epithelial cells has been demonstrated during airway infection, and attachment to epithelial cells is mediated by specific bacterial surface molecules (3, 18). Although epithelial cell receptors for these bacterial adhesive proteins have been more difficult to identify, the use of surface molecules on epithelial cells to detect and respond to infection by H. influenzae seems likely. Accordingly, we hypothesized that epithelial cells in the lung might have the capacity to detect infection with H. influenzae directly and then respond through activation of specific airway defense genes such as ICAM-1 and IL-8.

In the present study, we examined the airway epithelial response to H. influenzae using both an in vitro epithelial cell-bacteria interaction system and an in vivo murine infection model. Our results indicate that H. influenzae interaction with airway epithelial cells rapidly induces IL-8 production, ICAM-1 expression, and ICAM-1-dependent neutrophil adherence. Lipooligosaccharide (LOS)3 released from H. influenzae is not sufficient for direct induction of epithelial cell ICAM-1; instead, other molecules that appear to be present on the bacterial cell surface are required for this epithelial cell response. Epithelial cell ICAM-1 expression coincides with increased chemokine levels and neutrophil recruitment in a murine model of airway infection with H. influenzae, suggesting the physiologic relevance of this response to airway defense against bacteria. Direct induction of specific epithelial genes (such as ICAM-1 and IL-8) may allow for rapid targeting and activation of neutrophils at sites of H. influenzae infection, resulting in efficient innate defense in the airway.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Bacterial preparation and quantitation

The following bacteria were used: nontypable H. influenzae strain 12; a strain 12 mutant deficient in expression of the high m.w. (HMW) 1 and 2 adhesins (19); nontypable H. influenzae strain N187; a strain N187 mutant deficient in expression of the HMW1, HMW2, and Haemophilus adherence and penetration protein (Hap) adhesins (20); nontypable H. influenzae strain 11; a strain 11 mutant deficient in expression of the H. influenzae adhesin (Hia) (21); H. influenzae serotype b strain Eagan; an Eagan mutant lacking capsule expression (22); P. aeruginosa strains PAK and PA01 (gifts from S. Lory, University of Washington) (13, 23); Escherichia coli stains HB101 and DH5{alpha} (Life Technologies, Gaithersburg, MD); clinical isolates of Staphylococcus aureus (CDC1, 97-033191; CDC2, 97-033192; Centers for Disease Control and Prevention, Atlanta, GA); a clinical isolate of Streptococcus pneumoniae (St. Louis Children’s Hospital); and Bordetella pertussis strains Tohama I (virulent phase) and Tohama III (isogenic avirulent phase) (gifts from W. Goldman, Washington University) (24). H. influenzae was grown on chocolate blood agar supplemented with 1% Isovitalex (25) or in brain-heart infusion broth supplemented with haemin and NAD (22). P. aeruginosa and E. coli were grown on Luria-Bertani (LB) agar or in LB broth. S. aureus was grown on trypticase soy agar with 5% sheep blood (Becton Dickinson, Cockeysville, MD) or in Nutrient Broth No. 2 (Oxoid, London, U.K.). S. pneumoniae was grown on trypticase soy agar with 5% sheep blood or in Todd-Hewitt broth (Difco, Detroit, MI). B. pertussis was grown on agar or in broth containing modified Stainer-Scholte medium with supplements as described previously (24). To prepare aerated, log-phase bacteria, colonies from a fresh plate were inoculated into 3–20 ml of broth, and the culture was incubated with rotary shaking at 37°C until a turbidimetric estimate (OD600 = 0.6–0.7) of ~1–3 x 109 CFU/ml was achieved (1.5–2 h). Bacteria were quantitated by plating serial dilutions of broth cultures, culture media, epithelial cells, or homogenized lung or agar particles on solid agar media appropriate for each organism. LOS (a gift from M. Apicella, University of Iowa) was purified from nontypable H. influenzae strain 2019 by the phenol/chloroform/petroleum ether method (26). Diphosphoryl lipid A (a gift from N. Qureshi, University of Wisconsin) was purified from Rhodobacter sphaeroides as described previously (27).

Epithelial cell culture and infection

The A549 respiratory epithelial cell line (American Type Culture Collection CCL-185; Manassas, VA) was cultured in RPMI 1640 medium supplemented with 10% heat-inactivated (56°C for 1 h) FBS, 2 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, and 0.25 µg/ml amphotericin B. The BEAS-2B normal airway epithelial cell line (a gift from J. Lechner, National Cancer Institute) (28) was cultured in LHC-8e medium (29) in flasks coated with collagen/albumin as described previously (4, 9, 10, 11, 30). HUVEC (Clonetics, San Diego, CA) were maintained in supplemented endothelial basal medium in flasks coated with gelatin up to passage 10 as described previously (4, 6, 7, 9). The cystic fibrosis airway epithelial cell line IB3–1 (genotype {Delta}F508/W1282X) and the matched rescued cell line C38 (gifts from P. Zeitlin, Johns Hopkins University) (31, 32) were cultured in LHC-8 medium (29) supplemented with 5% FBS, 100 U/ml penicillin, 100 µg/ml streptomycin, 0.2 mg/ml imipenem (Merck, West Point, PA), 80 µg/ml tobramycin (Eli Lilly, Indianapolis, IN), and 2.5 µg/ml amphotericin B in flasks coated with collagen/albumin. Cells were cultured at 37°C in 5% CO2 and incubated with bacteria in the same media without antibiotics except as indicated. We have found that an inoculum of >=200 CFU/epithelial cell (107 CFU/ml of media) results in maximal ICAM-1 induction, correlating with a minimal requirement for bacterial growth to reach stationary phase levels (108–109 CFU/ml of media).

Enzyme-linked immunoassays

Protein levels on the surface of epithelial and endothelial cells at confluence on 24- or 96-well tissue culture plates were determined using an ELISA as described previously (4) with minor modifications. In some experiments, epithelial cells were separated from bacteria using a Transwell culture system with a 0.1-µm pore size polycarbonate membrane (Corning-Costar, Acton, MA), culturing the epithelial cells in the lower chamber and bacteria in the upper chamber. After incubation with bacteria, epithelial cell monolayers were washed in buffer consisting of PBS with 0.5% BSA, 1 mM CaCl2, and 1 mM MgCl2 and then fixed for 15 min at 25°C in 1% paraformaldehyde in PBS. The cell monolayer was thoroughly washed, and nonspecific Ags were blocked by exposure to a blocking solution (3% BSA in washing buffer) for 90 min at 37°C. The cells were then exposed to 1 µg/ml of murine mAb 84H10 against human ICAM-1 (Immunotech, Westbrook, ME), murine mAb B9.12.1 against human HLA-A,B,C/MHC class I (Immunotech), or control murine mAb for 1 h at 37°C. Concentrations of mAb that gave a maximal response on Ab-titration curves were used. Primary mAb binding was detected by incubation with 0.04 µg/ml F(ab')2 fragment-specific, goat anti-mouse IgG conjugated to HRP (Pierce, Rockford, IL) in blocking solution followed by 3,3',5,5'-tetramethylbenzidine plus H2O2 substrate (Pierce). The color reaction was stopped after 15 min by addition of an equal volume of 2 M H2SO4, and absorbance was determined at 450 nm using a spectrophotometric microplate reader (Bio-Rad, Hercules, CA). Values for control mAb were subtracted from values for ICAM-1 and MHC class I to control for background Ab binding. Cytokines (IL-1ß, IL-8, and TNF-{alpha}) released into epithelial cell culture media were assayed using quantitative sandwich enzyme-linked immunoassay kits (R&D Systems, Minneapolis, MN). According to the manufacturer, the sensitivity of these assay systems for IL-1ß is <1 pg/ml, for IL-8 is <10 pg/ml, and for TNF-{alpha} is <0.18 pg/ml.

RNA blot analysis

Total cellular RNA was isolated from epithelial cell monolayers after bacterial infection using guanidinium isothiocyanate lysis followed by either centrifugation through cesium chloride or a column isolation kit (Qiagen, Santa Clarita, CA) and was subjected to RNA blot analysis as described previously (4, 11). Probes were labeled with [{alpha}-32P]dCTP (>3000 Ci/mmol) by the random-primer technique (Multiprime; Amersham International, Little Chalfont, U.K.) and included: 1) a 1.4-kb XhoI fragment from pCD1.8 containing human ICAM-1 cDNA in pCDM8 (a gift from M. Dustin, Washington University and D. Staunton, Harvard University) (33); 2) a 0.55-kb XbaI-HindIII fragment from pHcGAP containing human GAPDH cDNA in pBR322 (American Type Culture Collection).

Bacterial adherence assay

Bacterial adherence to epithelial cells at confluence on 24-well tissue culture plates was quantified using an assay described previously (19). In brief, bacteria were inoculated onto epithelial cell monolayers in antibiotic-free media, and plates were centrifuged at 165 x g for 5 min to facilitate bacteria-epithelial cell contact. After incubation at 37°C in 5% CO2 for 30 min, monolayers were rinsed five times with PBS to remove nonadherent organisms and then released with 0.05% trypsin plus 0.5% EDTA in PBS. Well contents were agitated, and serial dilutions were plated on chocolate blood agar for bacterial quantitation.

Neutrophil adherence assay

Neutrophil adherence to epithelial cells at confluence on 96-well tissue culture plates was quantified using an assay modified from ones described previously (4, 6, 7). Neutrophils in whole blood from healthy donors were isolated by a one-step gradient through Polymorphoprep (Nycomed Pharma AS, Oslo, Norway) followed by two cycles of hypotonic lysis to remove contaminating erythrocytes. Cell suspensions (>95% neutrophils) were labeled with 1 µg/ml of calcein AM fluorescent marker (Molecular Probes, Eugene, OR) in calcium- and magnesium-free (CMF) HBSS containing 0.1% BSA for 30 min at 25°C. The labeled neutrophils were collected by centrifugation, counted, incubated in CMF-HBSS plus BSA containing 100 U/ml TNF-{alpha} (a gift from Genentech, South San Franscisco, CA) for 15 min at 37°C to activate adhesive proteins, and resuspended in CMF-HBSS plus BSA. Epithelial cell monolayers were washed thoroughly, and 3 x 105 neutrophils were added to each well in 100 µl of HBSS plus BSA containing calcium and magnesium. In some tissue culture wells, neutrophils were added that had been pretreated with 30 µg/ml of blocking murine mAb R15.7 against human ß2 integrin/CD18 (a gift from R. Rothlein, Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT) (34) or control murine mAb for 30 min at 37°C. In other wells, the cell monolayer was pretreated with 50 µg/ml of blocking F(ab) of murine mAb R6.5 against human ICAM-1 (a gift from R. Rothlein) (34) or control murine mAb F(ab) for 30 min at 37°C. Ab concentrations that caused maximal inhibition of neutrophil adherence were used (34, 35), and Abs were not removed during the subsequent adherence period. Neutrophil adherence was allowed to occur for 15 min at 37°C. Fluorescence of all neutrophils added to the well was quantitated using a fluorescence microplate reader (Molecular Devices, Sunnyvale, CA) set at {lambda}ex = 485 nm and {lambda}em = 538 nm. Nonadherent neutrophils were then removed by filling each well with HBSS plus BSA and centrifuging inverted plates for 2 min at 200 x g. This step was repeated, 100 µl HBSS plus BSA was added, and the fluorescence of neutrophils adherent to the monolayer in each well was determined using the microplate reader. Background fluorescence was determined from wells in which neutrophils were not added, and this background value was subtracted from values obtained from experimental wells. Measurements of fluorescence were converted to number of adherent neutrophils/well using the formula: (adherent fluorescence/total fluorescence) x (3 x 105 neutrophils). Preliminary experiments established a high correlation (r = 0.99) between measurements of neutrophils obtained by determining fluorescence vs the values obtained for manual cell counting (4, 6, 7).

Murine lung infection model

Nontypable H. influenzae strain 12 was incorporated into agar particles using a technique modified from ones described previously (36). Bacteria were harvested from a 20-ml aerated, log-phase culture by centrifugation (10,000 x g, 4°C, 10 min) and were resuspended in 2x infection buffer (1x = 100 mM NaCl, 10 mM KCl, 10 mM sodium phosphate, pH 7.4, 10 mM glucose, 2% casamino acids) at a concentration of ~2 x 109 CFU/ml. The bacterial suspension was warmed to 45°C, and 3 ml was mixed with 3 ml of molten 4% Noble Agar (Difco) at 45°C. The bacteria-agar mixture was aspirated into a syringe, and 3 ml was immediately injected through a 23-g needle into 27 ml of rapidly stirring 1x infection buffer at 4°C. This produced a suspension containing bacteria at ~108 CFU/ml incorporated into amorphous agar particles ranging in size from 30 to 200 µm. Four-week-old C57BL/6 mice (Taconic, Germantown, NY) housed under pathogen-free conditions were anesthetized with 87 mg/kg of ketamine HCl and 13 mg/kg of xylazine HCl injected i.m. Mice were then placed in an intubation apparatus (37) and orotracheally intubated with a 22-gauge i.v. catheter. A 30-µl volume of PBS, control agar particles, or bacteria-agar particle suspension at 37°C (followed by 100 µl of air) was injected into the airway, and the mice were allowed to recover.

Lung infection quantitation and immunohistochemistry

After a specified duration of infection, mice were anesthetized and then euthanized by cervical dislocation, the lungs were exposed, and the pulmonary vascular system was flushed via the right ventricle with sterile saline. For murine chemokine quantitation, the diaphagmatic lobe of the right lung was ligated at its root, removed, and stored at -80°C. After harvest at all time points, lung tissue was homogenized in 0.5 ml of 50 mM sodium phosphate, pH 6.0 containing 0.5% hexadecyltrimethylammonium bromide using a glass tissue grinder (Kontes Glass, Vineland, NJ) followed by sonication using a sonic dismembrator (Fisher Scientific, Pittsburgh, PA) set at 30%. Samples were cleared by centifugation at 15,000 x g for 15 min at 4°C, and murine CXC chemokines (KC and macrophage inflammatory protein-2 (MIP-2)) were assayed in supernatants using quantitative sandwich enzyme-linked immunoassay kits (R&D Systems). The sensitivity of these assay systems for KC is <2.0 pg/ml and for MIP-2 is <1.5 pg/ml. For bacterial quantitation, the left lung was ligated at its root and removed under sterile conditions, minced with a razor blade in a petri dish with 0.5 ml of PBS, and homogenized using a glass tissue grinder. Serial dilutions were then inoculated onto solid agar media for culture. For tissue staining, the trachea was cannulated with a 22-gauge i.v. catheter, and the right lung was inflated under 25 cm H2O pressure and fixed with 10% buffered formalin for 18 h. Paraffin-embedded 6-µm sections were deparaffinized in a D-limonene-based clearing solution (Stephens Scientific, Riverdale, NJ) and rehydrated in graded ethanol solutions. Serial sections stained with hematoxylin and eosin were used to assess inflammatory cell influx near agar particles. For ICAM-1 immunostaining of lung sections, endogenous peroxidase activity was blocked by treatment with 5% hydrogen peroxide for 5 min, and nonspecific Ags were blocked by exposure to a blocking solution (3% nonimmune goat serum in PBS) for 30 min at 25°C. Slides were then incubated with 2 µg/ml of hamster mAb 3E2 against murine ICAM-1 (PharMingen, San Diego, CA) or isotype-matched control hamster mAb for 18 h at 4°C. Primary Ab binding was detected by incubation with 7.5 µg/ml biotinylated goat anti-hamster IgG Ab (Vector Laboratories, Burlingame, CA) in blocking solution followed by streptavidin-conjugated HRP and 3,3'-diaminobenzidine plus H2O2 substrate (Vector Laboratories). Tissue sections were counterstained with hematoxylin, dehydrated in graded ethanol, and mounted for microscopy (Model D-7082; Carl Zeiss, Thornwood, NY). Images were acquired using a computerized digital camera system (SPOT-2; Diagnostic Instruments, Sterling Heights, MI) interfaced with Photoshop 5.0 software (Adobe Systems, San Jose, CA).

Statistical analysis

Neutrophil and bacterial adherence assays and enzyme-linked immunoassay were performed two to four times to insure reproducible results, and values from representative experiments were analyzed for statistical significance using a one-way ANOVA for a factorial experimental design. The multicomparison significance level for the one-way ANOVA was 0.05. If significance was achieved by one-way analysis, post-ANOVA comparison of means was performed using Scheffe F tests (38).


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
H. influenzae induces ICAM-1 expression on respiratory epithelial cells

ICAM-1 protein levels on the surface of cultured human respiratory epithelial cell monolayers were examined using an enzyme-linked immunoassay based on specific anti-ICAM-1 mAb (4). These experiments revealed low constitutive ICAM-1 expression on A549 respiratory epithelial cells and a marked increase in ICAM-1 levels after incubation for 24 h with nontypable H. influenzae strain 12 (Fig. 1GoA). Incubation of BEAS-2B human bronchial epithelial cells with H. influenzae strain 12 also resulted in a significant increase in ICAM-1 expression. The relative magnitude of induction was less marked with BEAS-2B cells, reflecting relatively high constitutive levels of ICAM-1 on these cells that do not recapitulate low levels of expression observed on tracheal and bronchial epithelial cells in vivo (4, 39). We also tested IB3–1 and C38 airway epithelial cells and found that these cell lines responded to H. influenzae by induction of cell-surface ICAM-1 at levels similar to those observed with BEAS-2B cells (results not shown). Examination of the relationship between inoculum and ICAM-1 induction revealed that lower inocula induced less ICAM-1 at early time points. The effect of inoculum size was less pronounced after 12 h, likely reflecting attainment of stationary phase and bacterial concentrations of 108–109 CFU/ml by this point, regardless of the initial inoculum (A.G.F. and D.C.L., unpublished observation).



View larger version (35K):
[in this window]
[in a new window]
 
FIGURE 1. H. influenzae induces ICAM-1 expression on respiratory epithelial cells. A, A549 and BEAS-2B cell monolayers were infected for 0, 12, or 24 h with 0.02 or 200 CFU/cell (103 or 107 CFU/ml) of nontypable H. influenzae strain 12. Levels of epithelial cell-surface ICAM-1 were assayed using anti-ICAM-1 mAb in an enzyme-linked immunoassay. Values are expressed as mean ± SD (n = 3–4), and a significant increase from uninfected levels is indicated by an asterisk. B, A549 cell monolayers were infected for 0–24 h with 200 CFU/cell of nontypable H. influenzae strain 12, and ICAM-1 mRNA levels were assessed by RNA blot analysis of total cellular RNA. The arrows indicate the positions of the 3.3-kb ICAM-1 and 1.3-kb GAPDH mRNAs.

 
To examine whether increased ICAM-1 surface protein detected by immunoassay was accompanied by increased ICAM-1 mRNA, RNA blot analysis of total cellular RNA from epithelial cells was performed. In experiments with A549 cells, ICAM-1 mRNA levels were also up-regulated after H. influenzae infection, with peak mRNA expression detected at 8 h, followed by a gradual decline (Fig. 1GoB). Taken together, these results suggest that H. influenzae has the ability to directly activate epithelial cell ICAM-1 expression through control of mRNA level, similar to regulation of this gene by certain cytokines (4).

P. aeruginosa also induces ICAM-1 expression on respiratory epithelial cells

To determine whether induction of ICAM-1 is a uniform response of respiratory epithelial cells to bacterial infection, we examined the epithelial response to several other respiratory pathogens. In performing these experiments, we incubated bacteria with A549 cell monolayers and then verified that each bacterial strain achieved a density of at least 108 CFU/ml (results not shown). Following incubation with epithelial cells for 24 h, H. influenzae type b strain Eagan induced cell-surface ICAM-1 expression similar in magnitude to that seen with nontypable H. influenzae strain 12 (Fig. 2GoA). In contrast, isolates of S. pneumoniae and B. pertussis failed to stimulate ICAM-1 expression. Experiments with P. aeruginosa were complicated by significant cytotoxic effects on the monolayer after 12 h of infection, possibly due to release of exotoxins or proteases. To circumvent this problem, we performed RNA blot analysis after infection of the monolayer with bacteria for 8 h (the time point of peak ICAM-1 mRNA expression after H. influenzae infection). Under these conditions, infection with P. aeruginosa induced slightly higher levels of epithelial cell ICAM-1 mRNA than did H. influenzae, while strains of E. coli and S. aureus had minimal effect (Fig. 2GoB). Although we cannot exclude the possibility that the culture system used affected the phenotype or growth of these bacterial species differently or that the isolates tested lack appropriate virulence factors required for this effect, our results suggest that selected bacterial species important in human lung infections have the capacity to induce respiratory epithelial cell ICAM-1 expression.



View larger version (25K):
[in this window]
[in a new window]
 
FIGURE 2. P. aeruginosa also induces ICAM-1 expression on respiratory epithelial cells. A, A549 cell monolayers were left uninfected or were infected for 24 h with 200 CFU/cell of H. influenzae (type b strain Eagan or nontypable strain 12), S. pneumoniae, or B. pertussis (strains Tohama I or III). Surface protein levels of ICAM-1 were assayed as in Fig. 1Go. Values are expressed as mean ± SD (n = 3–4), and a significant increase from uninfected levels is indicated by an asterisk. B, A549 cell monolayers were left uninfected or were infected for 8 h with 200 CFU/cell of H. influenzae (type b strain Eagan or nontypable strain 12), E. coli (strains HB101 or DH5{alpha}), P. aeruginosa (strains PAK or PA01), or S. aureus (isolates CDC1 or CDC2). ICAM-1 mRNA levels were assessed by RNA blot analysis as in Fig. 1Go. In A and B, monolayer integrity and bacteria viability and growth (to >108 CFU/ml) in culture were verified visually and by inoculating serial dilutions on solid media appropriate for each organism.

 
H. influenzae also induces IL-8 secretion from respiratory epithelial cells

Recent studies examining the interaction between P. aeruginosa and respiratory epithelial cells suggest that epithelial cells may participate in neutrophil recruitment to sites of infection through release of cytokines such as IL-8 (12, 13). To examine the effect of H. influenzae infection on other epithelial cell inflammatory mediators, we performed enzyme-linked immunoassays for epithelial cell expression of MHC class I and release of IL-1ß, IL-8, and TNF-{alpha}. Using A549 cells, we observed minimal effects on MHC class I surface expression and IL-1ß and TNF-{alpha} secretion (results not shown). In contrast, similar to observations with H292 lung epithelial cells (40), infection with H. influenzae resulted in high levels of IL-8 release (Fig. 3GoA). The time course for induction of IL-8 was similar to the relatively rapid expression of ICAM-1 in response to H. influenzae (Fig. 3GoB), suggesting preferential activation of a specific epithelial cell gene subset directed at early defense against bacteria. Because of the coordinated effects of IL-8 and ICAM-1 on neutrophils, this epithelial cell gene subset may be particularly important in mediating neutrophil recruitment and activation in the airway in response to bacteria.



View larger version (12K):
[in this window]
[in a new window]
 
FIGURE 3. H. influenzae also induces IL-8 secretion from respiratory epithelial cells. A549 cell monolayers were infected for 0–24 h with 200 CFU/cell of nontypable H. influenzae strain 12. Levels of epithelial cell secretion of IL-8 into media (A) and surface expression of ICAM-1 (B) were determined by enzyme-linked immunoassays. Values are expressed as mean ± SD (n = 3–4), and a significant increase from uninfected levels is indicated by an asterisk.

 
Respiratory epithelial cell interaction with a constitutive molecule on the surface of H. influenzae induces ICAM-1

To further define the nature of the interaction between H. influenzae and epithelial cells that results in increased ICAM-1 expression, we performed a set of experiments in which incubation conditions were adjusted to affect specific characteristics of the interaction (e.g., bacterial viability, direct bacteria-epithelial cell contact). In these experiments, sufficient inocula of nontypable H. influenzae strain 12 (>=108 CFU/ml) were added to epithelial cells to insure that treatment effects were not simply due to inhibition of bacterial growth. We found that treatment of H. influenzae with a bacteriostatic concentration of chloramphenicol sufficient to selectively inhibit bacterial protein synthesis (20, 40, 41) and killing of H. influenzae using a bactericidal dose of gentamicin had no significant effect on bacterial capacity for induction of epithelial cell ICAM-1 (Fig. 4GoA), suggesting that induction of ICAM-1 is mediated by a constitutive bacterial factor. However, sterile filtrate from a viable culture of H. influenzae in an amount equivalent to the volume added for a stationary-phase level of infection had minimal effect on epithelial cell ICAM-1 levels, indicating that the relevant bacterial factor(s) is not released from the organism or does not pass through a 0.2-µm pore-size polyethersulfone filter. To support this conclusion, direct interaction of H. influenzae with epithelial cells was compared with interaction between bacteria and epithelial cell monolayer separated (in media during the incubation period) by a 0.1-µm pore-size polycarbonate membrane. Despite the fact that a similar density of bacteria was achieved when H. influenzae was cultured above the filter compared with incubation in direct contact with epithelial cells (>109 CFU/ml), separation of bacteria from epithelial cells by a semipermeable membrane almost completely eliminated ICAM-1 and IL-8 induction (Fig. 4GoB).



View larger version (14K):
[in this window]
[in a new window]
 
FIGURE 4. Induction of ICAM-1 by H. influenzae requires epithelial cell interaction with a constitutive molecule on the bacterial cell surface. A, A549 cell monolayers were left uninfected or were infected for 24 h with 108 CFU/ml (stationary-phase level) of nontypable H. influenzae strain 12 that was left untreated, treated with 20 µg/ml of chloramphenicol (Chlor) or 100 µg/ml of gentamicin (Gent) for 15 min before and during the incubation period, or filtered through a sterile 0.2 µm polyethersulfone filter (Filtrate) before the incubation period. In some wells, epithelial cell monolayers were incubated with 100 µM dexamethasone (Dex) during the incubation period with untreated H. influenzae. Surface protein levels of ICAM-1 were assayed as in Fig. 1Go. Inoculation of serial dilutions of bacteria on chocolate agar plates after incubation demonstrated >108 CFU/ml in wells with bacteria that were untreated or treated with chloramphenicol or dexamethasone, but no viable organisms in wells with bacteria that were treated with gentamicin or filtered. B, A549 cell monolayers were left uninfected or were infected for 24 h with 108 CFU/ml of nontypable H. influenzae strain 12 that were in direct contact with the monolayer (Contact) or separated from the monolayer in media during the incubation period by a 0.1-µm pore-size polycarbonate membrane (Separate). Levels of epithelial cell-surface expression of ICAM-1 and secretion of IL-8 into media were determined by enzyme-linked immunoassays. Bacterial quantitation after incubation demonstrated >109 CFU/ml in wells with bacterial-epithelial cell contact and above the membrane in wells with separation, but no viable organisms below the membrane in wells with separation. C, A549 cell monolayers were left uninfected or were infected for 24 h with 108 CFU/ml of nontypable H. influenzae strain 12 that was left untreated, treated with 100 µg/ml of gentamicin (Gent) for 120 min before and during the incubation period, or treated with 0.1% paraformaldehyde (Para) for 15 min before incubation with epithelial cells. In some wells, bacteria were added that had been washed at least four times in PBS after treatment with gentamicin or paraformaldehyde. Surface protein levels of ICAM-1 were assayed as in Fig. 1Go. Bacterial quantitation after incubation demonstrated >108 CFU/ml in wells with bacteria that were untreated, but no viable organisms in wells with bacteria that were treated with gentamicin or paraformaldehyde. In AC, values are expressed as mean ± SD (n = 3–6), and a significant increase from uninfected levels is indicated by an asterisk.

 
To eliminate both new synthesis and constitutive presence of soluble bacterial factors that might induce ICAM-1 expression on epithelial cells, we pretreated H. influenzae with bactericidal concentrations of either gentamicin or paraformaldehyde and then washed the bacteria extensively. H. influenzae that were killed and washed maintained the capacity to induce epithelial cell ICAM-1 when bacteria were used that corresponded to inocula before treatment of >=108 CFU/ml (Fig. 4GoC). Bacteria that were treated with gentamicin and then washed induced levels of epithelial cell ICAM-1 that were similar to inocula that were untreated or gentamicin treated but not washed. H. influenzae that were treated with paraformaldehyde and then washed induced lower levels of ICAM-1, and this may reflect alteration of bacterial surface Ags induced by this treatment or a mild loss of bacteria that we observed with washing (results not shown). These findings indicate that H. influenzae induction of ICAM-1 is mediated by a factor not released from the bacterial surface and suggest that bacteria-epithelial cell contact is required for ICAM-1 induction. The release of a soluble factor from the bacteria that has physical characteristics that preclude significant permeability through separation membranes used in our experiments (e.g., tendency to adhere to the membranes or form large aggregates) seems less likely. Interestingly, treatment of epithelial cells with dexamethasone resulted in partial inhibition of ICAM-1 induction by H. influenzae (Fig. 4GoA), suggesting that the epithelial signaling pathway activated by the bacteria is affected by corticosteroids.

H. influenzae LOS does not induce ICAM-1 expression on respiratory epithelial cells

LPS is a component of the outer membrane of Gram-negative bacteria, but is also released during growth and death of these bacteria (42). Unlike enteric Gram-negative bacteria, Haemophilus, Bordetella, Moraxella, and Neisseria species synthesize a form of LPS containing an oligosaccharide linked to lipid A without repeating subunit O-Ag polysaccharide chains (referred to as lipooligosaccharide or LOS) (42, 43). H. influenzae LOS is highly hydrophobic, and its biochemical characteristics may limit permeability through the membranes we tested. Therefore, to directly assess the role of H. influenzae LOS in epithelial cell activation, we tested a highly purified form of LOS from nontypable H. influenzae (26) and used diphosphoryl lipid A purified from Rhodobacter sphaeroides (RsDPLA), which functions as a competitive LPS antagonist (27, 44). Biologic activity of these preparations was verified using the LPS-responsive HUVEC model, which revealed that H. influenzae LOS causes induction of ICAM-1 on HUVEC that is inhibitable with >=10-fold higher concentrations of RsDPLA (Fig. 5GoA). However, induction of ICAM-1 on A549 cells by both viable and gentamicin-treated H. influenzae was not inhibited by RsDPLA (Fig. 5GoB). Because RsDPLA does not have the capacity to block high levels of LPS due to its partial agonist activity at high concentrations (Fig. 5GoA), we tested purified H. influenzae LOS on A549 cells at concentrations (1–100 µg/ml) previously shown to be released by the bacteria (42). We found no induction of ICAM-1 on A549 cells by this LOS preparation despite high levels of induction on HUVEC (Fig. 5GoC). Although these results do not rule out the possibility that high levels of LOS are necessary for H. influenzae induction of epithelial cell ICAM-1 expression, they argue that LOS is not sufficient and another component of H. influenzae is required for this effect.



View larger version (19K):
[in this window]
[in a new window]
 
FIGURE 5. H. influenzae LOS does not induce ICAM-1 expression on respiratory epithelial cells. A, HUVEC monolayers were treated for 24 h with 0–0.1 µg/ml of purified nontypable H. influenzae LOS. Monolayers were also treated with 0–100 µg/ml of RsDPLA for 30 min before and during LOS treatment. Surface protein levels of ICAM-1 were assayed as in Fig. 1Go. A significant decrease from LOS- but not RsDPLA-treated levels is indicated by an asterisk. B, A549 cell monolayers were left uninfected, were infected for 24 h with 200 CFU/cell (107 CFU/ml) of viable nontypable H. influenzae strain 12, or were treated with 108 CFU/ml of strain 12 that was incubated with 100 µg/ml of gentamicin (Gent) for 15 min before and during the 24 h incubation period. Monolayers were also treated with 0–10 µg/ml of RsDPLA for 30 min before and during bacterial infection. Surface protein levels of ICAM-1 were assayed as in Fig. 1Go. A significant decrease from H. influenzae- but not RsDPLA-treated levels was not obtained. Bacterial quantitation after incubation demonstrated >108 CFU/ml in wells with bacteria that were untreated and no viable organisms in wells with bacteria that were treated with gentamicin. C, A549 and HUVEC monolayers were left uninfected, were infected with 200 CFU/cell of nontypable H. influenzae strain 12, or were treated with 0.1–100 µg/ml of purified nontypable H. influenzae LOS for 24 h. Surface protein levels of ICAM-1 were assayed as in Fig. 1Go. A significant increase from uninfected levels is indicated by an asterisk. In A–-C, values are expressed as mean ± SD (n = 3).

 
Role of known bacterial adhesins in H. influenzae induction of epithelial cell ICAM-1 expression

A number of proteins that promote adherence to epithelial cells have been identified on the surface of nontypable and type b strains of H. influenzae, and expression of these adhesins varies depending on the isolate (3). Approximately 75% of nontypable strains express high-molecular-weight adhesins referred to as HMW1 and HMW2 (45). Most of the remaining nontypable strains and virtually all type b strains express an adhesin called Hia or a homologous protein designated Hsf (21, 46). Among nontypable strains, an Hia homologue is universally absent from strains that express HMW1/HMW2-like proteins (21, 47). Another H. influenzae adhesin is the Hap serine protease (48), which is present in strains expressing HMW1 and HMW2 and possibly in other strains as well. In addition, selected isolates express hemaglutinating pili (49, 50).

To examine the potential role of each of these known H. influenzae adhesins in inducing epithelial cell ICAM-1 expression, we measured ICAM-1 levels on A549 cells incubated with a series of wild-type H. influenzae strains or isogenic adhesin-deficient mutants. In these experiments, the three wild-type nontypable strains (strains 12, N187, and 11), which lack the genes involved in pilus biogenesis, induced similar levels of ICAM-1 expression (Fig. 6GoA). Comparison of strain 12 to an isogenic mutant lacking HMW1 and HMW2 revealed a significant difference in adherence to A549 cells but no difference in ability to induce ICAM-1 expression (Fig. 6Go, A and B). Similarly, comparison of strain N187 and an isogenic mutant lacking HMW proteins and Hap demonstrated reduced adherence by the mutant strain but equivalent capacity to induce ICAM-1 expression on A549 cells. Strain 11 and a strain 11 mutant deficient in expression of Hia exhibited comparable levels of adherence to A549 cells (suggesting absence of the Hia receptor on these cells) and induced similar levels of ICAM-1. We also examined the effect of the type b capsule on H. influenzae adherence to A549 cells and induction of ICAM-1 expression. Of note, this bacterial capsule is known to interfere with the function of some adherence mechanisms but not others (22). We found that encapsulated strain Eagan demonstrated minimal stable adherence to A549 cells (Fig. 6GoB). Nevertheless, this strain was still effective at inducing epithelial cell ICAM-1 expression (Fig. 6GoA). Considered together, these results indicate that H. influenzae induction of epithelial cell ICAM-1 is independent of the HMW1, HMW2, Hia, and Hap adhesins, which promote high-affinity bacterial adherence. In addition, induction is independent of piliation, which appears to be associated with lower-affinity adherence (51). It is possible that ICAM-1 expression is mediated by other bacterial surface molecules involved in low-affinity, unstable interactions with epithelial cells.



View larger version (20K):
[in this window]
[in a new window]
 
FIGURE 6. Selected H. influenzae adhesins do not mediate increased ICAM-1 expression on respiratory epithelial cells. A, A549 cell monolayers were left uninfected or were infected for 24 h with 200 CFU/cell of nontypable H. influenzae strain 12 without or with mutation that inactivates expression of HMW1 and HMW2 (HMW-), strain N187 with or without HMW1, HMW2, and Hap expression (HMW-/Hap-), strain 11 with or without Hia expression (Hia-), or H. influenzae type b strain Eagan without or with mutation that blocks encapsulation (cap-). Surface protein levels of ICAM-1 were assayed as in Fig. 1Go, and a significant difference from the corresponding wild-type isolates was not obtained. Bacterial quantitation after incubation demonstrated >108 CFU/ml after infection with all bacterial strains. B, A549 cell monolayers were incubated for 30 min with ~107 CFU/monolayer of the same strains of H. influenzae as in A. Nonadherent bacteria were removed by washing and cells and bacteria were released by trypsin/EDTA treatment. Numbers of adherent bacteria were then determined by quantitative culture. Results are expressed as percent inoculum to control for slight variation in number of bacteria added between strains, and a significant difference from the corresponding wild-type isolate is indicated by an asterisk. In A and B, values are expressed as mean ± SD (n = 3–4).

 
H. influenzae induces ICAM-1-dependent neutrophil adherence to respiratory epithelial cells

To assess the functional activity of ICAM-1 induced on respiratory epithelial cells by H. influenzae, neutrophil adherence to A549 cells was determined before and after incubation with H. influenzae. Infection of A549 cells for 24 h with H. influenzae strain 12 resulted in enhanced epithelial-neutrophil adherence using an in vitro assay system (Fig. 7Go). Specific blocking mAb were added to the assay to determine the contribution of epithelial cell ICAM-1 and its leukocyte counterreceptors, members of the ß2 integrin (CD18) family. We found that increased epithelial-neutrophil adherence after epithelial cell infection with H. influenzae was almost completely inhibitable by treatment with anti-ICAM-1 or anti-CD18 mAbs. The more efficient blockade that we observed with anti-CD18 compared with anti-ICAM-1 mAb is consistent with other reports (4, 5) and may reflect interactions between other epithelial cell surface molecules and leukocyte CD18 receptors. The expression of functional ICAM-1 in response to H. influenzae infection confirms that this mechanism could contribute to neutrophil recruitment or activation in the airway.



View larger version (19K):
[in this window]
[in a new window]
 
FIGURE 7. H. influenzae induces ICAM-1-dependent neutrophil adherence to respiratory epithelial cells. Neutrophils were isolated, fluorescence-labeled with calcein, activated with 100 U/ml TNF-{alpha} for 15 min, and allowed to adhere to A549 cell monolayers that had been left uninfected or had been infected for 24 h with 200 CFU/cell of nontypable H. influenzae strain 12 (monolayers were washed of bacteria before adding neutrophils). Neutrophil adherence to epithelial cell monolayers was determined by measurement of fluorescence before and after removal of nonadherent neutrophils by washing. Monolayers and neutrophils were studied without Abs, after pretreatment of the monolayer with control or anti-ICAM-1 mAb F(ab), or after pretreatment of neutrophils with control or anti-CD18/ß2 integrin mAb. Values are expressed as mean ± SD (n = 3–4), and a significant decrease from infected but untreated with mAb levels is indicated by an asterisk.

 
H. influenzae induces leukocyte recruitment and ICAM-1 expression in vivo

To examine the in vivo epithelial cell response to H. influenzae, we modified a murine model of bacterial airway infection that has been used to examine the pulmonary response to respiratory pathogens, including H. influenzae (36, 52). In this model, small airway entrapment of agar particles impairs bacterial clearance from the lung, resulting in infection and leukocyte recruitment in the airway. Because a murine structural homologue for human IL-8 has not been identified (53), we determined the levels of KC and MIP-2, which are functional CXC chemokine homologues for IL-8 due to their ability to induce neutrophil chemotaxis (54, 55, 56). Similar to other models of pulmonary infection (54, 55, 56), high levels of these chemokines were detected in the lungs of mice infected with H. influenzae for 24 h (Fig. 8Go). KC and MIP-2 levels were lower after 72 h of infection compared with the 24-h time point. The expression of these chemokines may account for selective neutrophil recruitment early in the course of bacterial infection in the lung.



View larger version (19K):
[in this window]
[in a new window]
 
FIGURE 8. H. influenzae infection increases CXC chemokine levels in murine lung. Nontypable H. influenzae strain 12 or control buffer was incorporated into agar particles, and 30 µl of control agar particles or particles containing ~107 CFU was inoculated into the trachea and bronchi of C57BL/6 mice. At the indicated times after inoculation, the lungs were harvested, and levels of KC and MIP-2 in lung homogenates were determined using enzyme-linked immunoassays. Values are expressed as mean ± SD (n = 3 in each group), and a significant increase from levels in animals inoculated with control agar particles is indicated by an asterisk.

 
We also examined epithelial cell expression of ICAM-1 in response to H. influenzae infection in the airway. Of note, no bacteria were cultured from the lungs of mice that underwent control intratracheal injections, while mice injected with particles containing H. influenzae developed increasing lung bacterial burden over a 72-h period (Fig. 9Go). Immunohistochemical analysis of lungs from these mice revealed few leukocytes and little ICAM-1 in the airway epithelium at 24 h after injection of either PBS or agar particles without bacteria. High-level constitutive expression of ICAM-1 on type I alveolar epithelial cells served as a positive control for ICAM-1 staining in each sample (39). There was also minimal leukocyte influx and ICAM-1 expression in the airways of mice infected for 4 h by particles containing H. influenzae. However, we observed greatly increased numbers of leukocytes (particularly neutrophils) located near agar particles and increased airway epithelial cell ICAM-1 staining in samples from mice infected for 24 h. Thus, airway epithelial cell ICAM-1 expression after infection with H. influenzae was time dependent in a pattern that correlated with our in vitro studies. Increased leukocyte numbers persisted in the airways of mice after 72 h of infection, although airway ICAM-1 staining was decreased at this time point compared with the 24-h time point. Leukocytes localized predominantly in the airway lumen during infection, consistent with the concept that epithelial cell expression of ICAM-1 is responsible for a component of leukocyte recruitment and/or activation in the airway.



View larger version (86K):
[in this window]
[in a new window]
 
FIGURE 9. H. influenzae infection induces leukocyte recruitment and ICAM-1 expression in murine airway epithelium. Nontypable H. influenzae strain 12 or control buffer was incorporated into agar particles, and 30 µl of PBS, control agar particles, or particles containing ~106 CFU was inoculated into the trachea and bronchi of C57BL/6 mice (n = 4 in each group). At the indicated times after inoculation, the left lung was harvested for bacterial quantitation and the right lung was harvested for histopathologic study in which serial sections were stained using hematoxylin and eosin (AE) to visualize inflammation near agar particles or immunostained (FJ) to visualize ICAM-1. Similar sized airways and agar particles were selected for photomicrographs to allow for comparison. Agar particles are indicated by an asterisk, and epithelial cell ICAM-1 expression (brown staining) is indicated by arrowheads. No detectable staining was observed for nonimmune IgG. Bar size, 36 µm for AE and 18 µm for FJ.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Leukocyte traffic into and through epithelial tissues is a critical feature of airway defense function. However, little is known about mechanisms for leukocyte migration across epithelia and activation in response to bacterial infection. This report indicates that direct interaction between epithelial cells and H. influenzae results in induction of specific epithelial cell genes that can assist in airway defense. Induction of ICAM-1 on epithelial cells by H. influenzae may contribute to leukocyte migration through the epithelium into the airway and/or activation of leukocyte antibacterial mechanisms that assist in clearance of infection. Soluble mediators (e.g., IL-8) are also involved in this process by targeting a specific leukocyte subset (e.g., neutrophils) directly to areas of infection (8). Neutrophil recruitment into the airway in response to infection may be directed by soluble or cell-surface mediator gradients and the preference for migration from the basal to apical side of airway epithelial cells in response to chemoattractants (41, 57). Although the complex interplay between the many mediators and factors that take part in this process is only beginning to be understood, the present findings provide further evidence that epithelial cells in the lung take an active role in pulmonary defense against microbial pathogens.

Using four respiratory epithelial cell lines, we observed that infection with H. influenzae directly stimulated ICAM-1 expression, suggesting that this mechanism could function in concert with cytokine-dependent expression and may be generalized to airway epithelial cell behavior in vivo. Given that unstimulated type II alveolar, tracheal, and bronchial epithelial cells generally express low ICAM-1 levels in vivo (4, 39), we performed many of our experiments using the A549 epithelial cell line, which also displays low levels of constitutive ICAM-1, allowing us to maximize detection of increased expression in response to bacteria. Interestingly, direct induction of ICAM-1 expression and cytokine secretion in response to microbial infection has also been reported for nonrespiratory epithelial cells, although the mechanism and cytokine profile of response is not always the same. These examples include: 1) increased IL-8, GM-CSF, TNF-{alpha}, and ICAM-1 by human mucosal epithelial cells after infection with Neisseria gonorrhoeae (58, 59); 2) increased IL-6, IL-8, and ICAM-1 by human uroepithelial cells after infection with uropathogenic E. coli (60); and 3) increased IL-8, TNF-{alpha}, GM-CSF, monocyte chemotactic protein-1, and ICAM-1 by human intestinal epithelial cells after invasion by several strains of Gram-positive and Gram-negative bacteria (61, 62). Thus, our observation of respiratory epithelial cell secretion of IL-8 and expression of ICAM-1 in response to H. influenzae infection fits well with the concept that host epithelial cells interacting with potentially pathogenic organisms have evolved mechanisms to activate defense responses when infection occurs. Bacterial induction of host cell mediators is generally rapid, suggesting that these mechanisms allow for early mobilization of inflammatory cells to defend the host at sites of infection.

Mammalian cell responses to the presence of bacteria are often initiated through detection of specific bacterial products, such as components of LPS, pili, or peptidoglycan (13, 24, 63, 64). Determinants for activation of epithelial cell defense genes in response to bacteria depend on physical characteristics of the bacterial stimuli, including whether factors are constitutively produced, expressed on the cell surface, and/or released by the bacteria. Our findings suggest that increased epithelial ICAM-1 expression after H. influenzae infection requires direct epithelial cell contact (possibly through a low-affinity interaction) with a constitutive molecule on the bacterial cell surface. However, for several reasons, we directed initial experiments toward determining if released LOS played a role in epithelial cell ICAM-1 induction. First, LPS induces a variety of responses in mammalian cells and may regulate cytokine gene expression in airway epithelial cells (26, 63, 64). Second, we could not initially exclude the possibilities that a bacterial extracellular factor that induces epithelial cell ICAM-1 may have physical characteristics (presumably other than molecular size) precluding significant permeability through 0.2- and 0.1-µm membranes or that bacteria-associated LOS may activate epithelial cells. Lastly, partially purified LOS from nontypable H. influenzae has been reported to increase cytokine release and ICAM-1 expression on isolated airway epithelial cells from smokers with lung cancer (65). However, the H. influenzae LOS used for this previous study was a partially purified preparation used at high concentration, and we postulate that impurities in that preparation might include other non-LOS factor(s) that induce ICAM-1 expression on epithelial cells.

Our work provides multiple lines of evidence that LOS is not responsible for induction of epithelial cell ICAM-1 by H. influenzae. We were unable to induce this effect by high levels of purified LOS from H. influenzae. As a corollary, we were unable to inhibit induction of epithelial cell ICAM-1 expression using a specific competitive inhibitor of LPS. In addition, we found that incubation with other LPS-releasing Gram-negative bacteria (B. pertussis and E. coli) at similar levels of infection did not induce epithelial cell ICAM-1. Furthermore, the absence of serum and thus the serum-associated LPS cofactors LPS-binding protein and soluble CD14 (64, 66) in culture media had no effect on H. influenzae induction of epithelial cell ICAM-1 (A.G.F. and D.C.L., unpublished observation). We and others have previously been unable to induce ICAM-1 expression or IL-8 release in human respiratory epithelial cells by several different preparations of LPS from other organisms, including E. coli (Refs. 13 and 67 and A.G.F. and D.C.L., unpublished observation). Although there are clearly structural differences between H. influenzae LOS and other forms of LPS, the biologic activity of LPS resides in the lipid A moiety, and the presence and structural characteristics of lipid A are highly conserved in diverse Gram-negative bacteria, including E. coli and H. influenzae (63, 64, 68). The relative lack of sensitivity for airway epithelial cell ICAM-1 expression in response to LPS likely reflects the fact that epithelial cells are continuously exposed to many bacterial products in the environment, and therefore other factors are used by epithelial cells to differentiate bacterial presence from infection. Interestingly, epithelial expression of the adenoviral oncoprotein E1A changes the epithelial phenotype into one that is LPS responsive, suggesting that factors in the environment may alter LPS signaling pathways in epithelial cells (69, 70). Although our results indicate that epithelial cells in the airway are not responsive to LOS alone, they do not rule out the possibility that LOS may be necessary or contribute to ICAM-1 induction by another factor. This system could be analogous to that for induction of epithelial cell IL-6 in which it appears that other as yet unidentified factors work in synergy with H. influenzae LOS (40, 65, 71).

Bacterial attachment to epithelial cells is fundamental to the process of colonization and to the pathogenesis of disease and is mediated by bacterial factors called adhesins, which interact with specific host cell-surface structures (3). Adhesins on the surface of H. influenzae include polymeric structures such as hemagglutinating pili and monomeric or oligomeric molecules, including HMW1, HMW2, Hia, and Hap. Nontypable strain 12 does not express pili (3, 50), yet this strain was capable of activating epithelial cell ICAM-1 expression, suggesting that other H. influenzae factors mediate this response. Isogenic mutants lacking HMW1, HMW2, Hia, and/or Hap retained the capacity to induce epithelial cell ICAM-1, suggesting that these adhesins are not essential for this effect. Similarly, an encapsulated type b strain was capable of inducing ICAM-1 despite the fact that encapsulation interferes with the function of nonpilus adhesins and virtually eliminated adherence to A549 cells. Our work suggests that the factors that induce epithelial cell ICAM-1 are not the high-affinity adhesins that are presumably used by H. influenzae for initial bacterial adherence and colonization. It is interesting to speculate that progression from colonization to disease requires interaction between low-affinity bacterial factors and the epithelial cell surface, thereby activating the inflammatory response.

The possible physiologic significance of our findings was indicated by demonstrating increased ICAM-1-dependent neutrophil adherence to epithelial cells in vitro after infection with H. influenzae. This finding was supported further by a murine model of pulmonary infection in which airway infection resulted in neutrophil recruitment and increased CXC chemokine levels that coincided with increased epithelial cell ICAM-1 expression. In this model, agar particles were used to impair clearance of bacteria because we have found that mice without impaired airway function generally clear H. influenzae within 24 h (L.P. and D.C.L., unpublished observation). This requirement for decreased airway clearance may be similar in humans in which preexisting lung diseases associated with airway dysfunction (e.g., cystic fibrosis, bronchiectasis, bronchitis) predispose patients to infection with H. influenzae. The in vivo model system used for our studies does not differentiate the role of direct interaction between bacteria and epithelial cells from the better understood cytokine-dependent mechanisms for inflammatory gene regulation. IFN-{gamma} and TNF-{alpha} appear to be the predominant cytokine stimulants of airway epithelial cell ICAM-1 expression (4, 5, 67), and epithelial cell induction of ICAM-1 by LPS in vivo may be TNF-{alpha} dependent (72). However, rapid induction of ICAM-1 and other mediators by direct bacterial interaction with epithelial cells, independent of inflammatory mediator release by other cell types, may allow for early targeting of neutrophils to sites of H. influenzae infection resulting in efficient innate defense in the airway. Taken together, our findings suggest a model for leukocyte migration and activation in the airway in which expression of cell adhesion molecules and chemokines by epithelial cells in response to bacterial infection may be mediated both indirectly through communication with other cell types by cytokines and/or directly by bacteria in the airway.


    Acknowledgments
 
We gratefully acknowledge M. Apicella, M. Dustin, W. Goldman, J. Lechner, S. Lory, N. Qureshi, R. Rothlein, D. Staunton, and P. Zeitlin for generous gifts of reagents; S. Brody, D. Dean, W. Goldman, and M. Holtzman for helpful discussion; and D. Cutter and D. Dickhaus for technical assistance.


    Footnotes
 
1 This research was supported by grants from the National Institutes of Health and the Cystic Fibrosis Foundation. Back

2 Address correspondence and reprint requests to Dr. Dwight C. Look, Washington University School of Medicine, Campus Box 8052, 660 South Euclid Avenue, St. Louis, MO 63110. E-mail address: Back

3 Abbreviations used in this paper: LOS, lipooligosaccharide; HMW, high m.w.; CMF, calcium- and magnesium-free; Hap, Haemophilus adherence and penetration protein; Hia, H. influenzae adhesin; LB, Luria-Bertani; LHC, Laboratory of Human Carcinogenesis; MIP-2, macrophage inflammatory protein-2; RsDPLA, Rhodobacter sphaeroides diphosphoryl lipid A. Back

Received for publication July 20, 1999. Accepted for publication February 4, 2000.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Holtzman, M. J., D. C. Look, D. Sampath, M. Castro, T. Koga, M. J. Walter. 1998. Control of epithelial immune-response genes and implications for airway immunity and inflammation. Proc. Assoc. Am. Phys. 110:1.[Medline]
  2. Beachey, E. H.. 1981. Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surfaces. J. Infect. Dis. 143:325.[Medline]
  3. III St. Geme, J. W.. 1996. Molecular determinants of the interaction between Haemophilus influenzae and human cells. Am. J. Respir. Crit. Care Med. 154:S192.
  4. Look, D. C., B. T. Keller, S. R. Rapp, M. J. Holtzman. 1992. Selective induction of intercellular adhesion molecule-1 by interferon-{gamma} in human airway epithelial cells. Am. J. Physiol. 263:L79.[Abstract/Free Full Text]
  5. Tosi, M. F., J. M. Stark, C. W. Smith, A. Hamedani, D. C. Gruenert, M. D. Infeld. 1992. Induction of ICAM-1 expression on human airway epithelial cells by inflammatory cytokines: effects on neutrophil-epithelial cell adhesion. Am. J. Respir. Cell Mol. Biol. 7:214.
  6. Nakajima, S., D. C. Look, W. T. Roswit, M. J. Bragdon, M. J. Holtzman. 1994. Selective differences in vascular endothelial- vs. airway epithelial-T cell adhesion mechanisms. Am. J. Physiol. 267:L422.[Abstract/Free Full Text]
  7. Nakajima, S., W. T. Roswit, D. C. Look, M. J. Holtzman. 1995. A hierarchy for integrin expression and adhesiveness among T cell subsets that is linked to TCR gene usage and emphasizes V{delta}1+ {gamma}{delta} T cell adherence and tissue retention. J. Immunol. 155:1117.[Abstract]
  8. Nakamura, H., K. Yoshimura, H. A. Jaffe, R. G. Crystal. 1991. Interleukin-8 gene expression in human bronchial epithelial cells. J. Biol. Chem. 266:19611.[Abstract/Free Full Text]
  9. Look, D. C., M. R. Pelletier, M. J. Holtzman. 1994. Selective interaction of a subset of interferon-{gamma} response element binding proteins with the intercellular adhesion molecule-1 (ICAM-1) gene promoter controls the pattern of expression on epithelial cells. J. Biol. Chem. 269:8952.[Abstract/Free Full Text]
  10. Look, D. C., M. R. Pelletier, R. M. Tidwell, W. T. Roswit, M. J. Holtzman. 1995. Stat1 depends on transcriptional synergy with Sp1. J. Biol. Chem. 270:30264.[Abstract/Free Full Text]
  11. Look, D. C., W. T. Roswit, A. G. Frick, Y. Gris-Alevy, D. M. Dickhaus, M. J. Walter, M. J. Holtzman. 1998. Direct suppression of Stat1 function during adenoviral infection. Immunity 9:871.[Medline]
  12. Massion, P., H. Inoue, J. Richman-Eisenstat, D. Grunberger, P. G. Jorens, B. Houssel, J. P. Wiener-Kronish, J. Nadel. 1994. Novel Pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro. J. Clin. Invest. 93:26.
  13. DiMango, E., H. J. Zar, R. Bryan, A. Prince. 1995. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J. Clin. Invest. 96:2204.
  14. Murphy, T. F., S. Sethi. 1992. Bacterial infection in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 146:1067.[Medline]
  15. van Alphen, L., D. A. Caugant, B. Duim, M. O’Rourke, L. D. Bowler. 1997. Differences in genetic diversity of nonencapsulated Haemophilus influenzae from various diseases. Microbiology 143:1423.[Abstract]
  16. Turk, D. C.. 1984. The pathogenicity of Haemophilus influenzae. J. Med. Microbiol. 18:1.[Medline]
  17. Konstan, M. W., K. A. Hilliard, T. M. Norvell, M. Berger. 1994. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am. J. Respir. Crit. Care Med. 150:448.[Abstract]
  18. Hers, J. F. P., J. Mulder. 1953. The mucosal epithelium of the respiratory tract in muco-purulent bronchitis caused by Haemophilus influenzae. J. Pathol. Bacteriol. 56:103.
  19. III St. Geme, J. W., S. Falkow, S. J. Barenkamp. 1993. High-molecular-weight proteins of nontypable Haemophilus influenzae mediate attachment to human epithelial cells. Proc. Natl. Acad. Sci. USA 90:2875.[Abstract/Free Full Text]
  20. Hendrixson, D. R., III. J. W. St. Geme. 1998. The Haemophilus influenzae Hap serine protease promotes adherence and microcolony formation, potentiated by a soluble host protein. Mol. Cell 2:841.[Medline]
  21. Barenkamp, S. J., III. J. W. St. Geme. 1996. Identification of a second family of high-molecular-weight adhesion proteins expressed by non-typable Haemophilus influenzae. Mol. Microbiol. 19:1215.[Medline]
  22. III St. Geme, J. W., D. Cutter. 1996. Influence of pili, fibrils, and capsule on in vitro adherence of Haemophilus influenzae type b. Mol. Microbiol. 21:21.[Medline]
  23. Ishimoto, K. S., S. Lory. 1989. Formation of pilin in Pseudomonas aeruginosa requires the alternative {varsigma} factor (RpoN) of RNA polymerase. Proc. Natl. Acad. Sci. USA 86:1954.[Abstract/Free Full Text]
  24. Cookson, B. T., H. L. Cho, L. A. Herwaldt, W. E. Goldman. 1989. Biological activities and chemical composition of purified tracheal cytotoxin of Bordetella pertussis. Infect. Immun. 57:2223.[Abstract/Free Full Text]
  25. Simon, C., G. Kreller, A. Bahr, D. Kiosz. 1984. In vitro comparison of fluid blood culture media. Infection 12:64.[Medline]
  26. Nichols, W. A., C. R. H. Raetz, T. Clementz, A. L. Smith, J. A. Hanson, M. R. Ketterer, M. Sunshine, M. A. Apicella. 1997. htrB of Haemophilus influenzae: determination of biochemical activity and effects o